Posted On: 02/10/2015 6:22:57 PM
Post# of 30065
Yes, I know the acquisitions. They did absolutely nothing for the share price.
I am just a little frustrated that another conference has put us in the red with no revenue/grant/JV announcement. Most notably, I was holding out hopes for something from the MJFF today.
To me, GC saying we are close to a Lympro sale means nothing. He has exaggerated statements in the past, so until I see some numbers it is just lip service, in my opinion. Anyone can say they are in discussions about selling something.
The Lympro revenue carrot has been dragged out long enough. Along with the financial engineering, changing the math, shareholder value, catalysts, inflection points, grants, partnerships, and the list goes on. At what point will GC deliver on anything?
The recent acquisitions were not catalysts. A catalyst would put us over 8 cents a share.
End of rant.
I am just a little frustrated that another conference has put us in the red with no revenue/grant/JV announcement. Most notably, I was holding out hopes for something from the MJFF today.
To me, GC saying we are close to a Lympro sale means nothing. He has exaggerated statements in the past, so until I see some numbers it is just lip service, in my opinion. Anyone can say they are in discussions about selling something.
The Lympro revenue carrot has been dragged out long enough. Along with the financial engineering, changing the math, shareholder value, catalysts, inflection points, grants, partnerships, and the list goes on. At what point will GC deliver on anything?
The recent acquisitions were not catalysts. A catalyst would put us over 8 cents a share.
End of rant.
(0)
(0)
